New stem cell treatment may offer hope for Parkinson’s disease
On Feb. 4, 2026, Keck Medicine of the University of Southern California (USC) announced it is conducting an early phase clinical…
Lilly selects Pennsylvania for new injectable medicine and device manufacturing facility
On Jan. 30, 2026, Eli Lilly announced plans to invest more than $3.5 billion in a new manufacturing…
Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless
On Jan. 28, 2026, U.S. drugmaker Eli Lilly announces signing an agreement worth up to $1.12 billion with…
US EPA moves to take action on review of fluoride in drinking water
On Jan. 28, 2026, the U.S. Environmental Protection Agency (EPA) launched the first step of its expedited review…
Google DeepMind launches AI tool to help identify genetic drivers of disease
On Jan. 28, 2026, researchers at Google DeepMind have unveiled their latest artificial intelligence tool and claimed it…
Menopause linked to loss of grey matter in the brain, poorer mental health and sleep disturbance
On Jan. 27, 2026, a University of Cambridge study shows menopause is linked to reductions in grey matter…
UCLA chemists just broke a 100-year-old rule and say it’s time to rewrite the textbooks
On Jan. 23, 2026, chemists from the University of California, Los Angeles (UCLA) have found a big problem…
New atlas could help researchers studying neurological disease
On Jan. 22, 2026, researchers backed by a Knight Initiative for Brain Resilience Catalyst Momentum Award have laid out…
Study reveals genetic factors influencing pregnancy loss
On Jan. 21, 2026, a Johns Hopkins University-led team demonstrated robust connections between specific variations in a mother’s…
Artificial Intelligence | Biotechnology | Diagnostics | Medical Device | Oncology | Quantum | Therapeutics
Oxford team engineer quantum-enabled proteins, opening a new frontier in biotechnology
On Jan. 21, 2026, in a world first, a research team led by the University of Oxford’s Department…
Researchers pinpoint biomarkers for schizophrenia
On Jan. 20, 2026, researchers announced they have identified two biomarkers — verbal learning and identifying other peoples’…
Researchers discover potential new target to treat Parkinson’s disease
On Jan. 15, 2026, a team of Case Western Reserve University researchers announced they have discovered a particular…
Biotechnology | Clinical Research | Diagnostics | FDA | Genomics | Infectious Disease | Medical Device | Medicine | Non-Profit Research | Oncology | Ophthalmogy | Organ Transplant | Pharmaceutical | Rare Disease | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. healthcare spending soars to over $5 trillion in 2024
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
AI model built by Yale and Google team finds new way to treat cancer
On Jan. 13, 2026, collaborating with Google’s top artificial intelligence labs, a team of Yale researchers announced they…
Diagnostics | Disease | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress | Women's Health
American Cancer Society Reports a Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
AbbVie and U.S. Administration Reach Agreement to Improve Access and Affordability for Americans
On Jan. 12, 2026, AbbVie announced a voluntary agreement with the Trump administration to further advance access and…
AbbVie Acquires Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the U.S.
On Jan. 12, 2026, AbbVie and West Pharmaceutical Services announced a definitive agreement for AbbVie to acquire a…
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida
On Jan. 9, 2026, Novartis announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in…
Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025
On Jan. 8, 2026, Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier…
Biology | Diagnostics | Disease | Oncology | Therapeutics
New research uncovers critical DNA repair mechanism during cell division
On Jan. 8, 2026, a major advance in cell biology has revealed how our cells safeguard their genetic…
How some people get drunk from their own gut bacteria
On Jan. 8, 2026, researchers reported results from a study on the largest cohort of autobrewery syndrome (ABS)…
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
Diagnostics | Environmental | EPA | Forestry | Infectious Disease | Non-Profit Research | Oncology | Therapeutics
respiratory infections remain the world’s leading infectious cause of death
On Jan. 6, 2026, a systematic analysis for the Global Burden of Disease Global study shows that lower…
Some antibodies outmaneuver germs from sticking to cells
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
Biotechnology | CMO | CRO | Genomics | Therapeutics | Vaccine
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…